Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Koopman

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2014
Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studiesSabine Venderbosch, Iris D Nagtegaal, Tim S Maughan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2020
European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatmentJeroen W G Derksen, Graham W Warren, Karin Jordan, et al.
Journal of the National Cancer Institute|March 18, 2021
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD DatabaseRomain Cohen, Heshan Liu, Jack Fiskum, et al.
The Lancet. Oncology|October 17, 2016
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseJan Franko, Qian Shi, Jeffrey P Meyers, et al.
Cancers|May 28, 2022
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide CohortKaren Bolhuis, G Emerens Wensink, Marloes A G Elferink, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2026
Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trialDania Al-Toma, Ruby Kemna, Mahsoem Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2016
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by ImmunohistochemistryAnne Trinh, Kari Trumpi, Felipe De Sousa E Melo, et al.
International Journal of Cancer|September 8, 2025
A comparison by mismatch repair status of real-world characteristics and outcomes in patients with stage II/III rectal cancer in the NetherlandsRenee A Lunenberg, Ingrid A Franken, Frederieke H van der Baan, et al.
Lancet (London, England)|July 17, 2007
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trialMiriam Koopman, Ninja F Antonini, Joep Douma, et al.
BMC Cancer|April 13, 2022
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancerSanne Ten Hoorn, Cynthia Waasdorp, Martijn G H van Oijen, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2014
Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studiesSabine Venderbosch, Iris D Nagtegaal, Tim S Maughan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2020
European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatmentJeroen W G Derksen, Graham W Warren, Karin Jordan, et al.
Journal of the National Cancer Institute|March 18, 2021
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD DatabaseRomain Cohen, Heshan Liu, Jack Fiskum, et al.
The Lancet. Oncology|October 17, 2016
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseJan Franko, Qian Shi, Jeffrey P Meyers, et al.
Cancers|May 28, 2022
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide CohortKaren Bolhuis, G Emerens Wensink, Marloes A G Elferink, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2026
Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trialDania Al-Toma, Ruby Kemna, Mahsoem Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2016
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by ImmunohistochemistryAnne Trinh, Kari Trumpi, Felipe De Sousa E Melo, et al.
International Journal of Cancer|September 8, 2025
A comparison by mismatch repair status of real-world characteristics and outcomes in patients with stage II/III rectal cancer in the NetherlandsRenee A Lunenberg, Ingrid A Franken, Frederieke H van der Baan, et al.
Lancet (London, England)|July 17, 2007
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trialMiriam Koopman, Ninja F Antonini, Joep Douma, et al.
BMC Cancer|April 13, 2022
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancerSanne Ten Hoorn, Cynthia Waasdorp, Martijn G H van Oijen, et al.
Pageof 20